Docetaxel-induced peripheral neuropathy: Protective effects of dihydroprogesterone and progesterone in an experimental model

Journal of the Peripheral Nervous System

Volumn 14, Issue 1, 2009, Pages 36-44

  Roglio, Ilaria ^a   Bianchi, Roberto ^b   Camozzi, Francesca ^c   Carozzi, Valentina ^d   Cervellini, Ilaria ^b   Crippa, Donatella ^e   Lauria, Giuseppe ^c   Cavaletti, Guido ^d   Melcangi, Roberto C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e Bayer Health Care Bayer Schering Pharma   (Italy)

Author keywords

Myelin proteins; Neuroactive steroids; Neuroprotection; Neurotoxicity; Nociception

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; CALCITONIN GENE RELATED PEPTIDE; COMPLEMENTARY RNA; DOCETAXEL; MYELIN PROTEIN; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LUMBAR SPINAL CORD; MALE; NERVE CONDUCTION; NERVE DEGENERATION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; RIBONUCLEASE PROTECTION ASSAY; SCIATIC NERVE; THERMAL STIMULATION;

20-ALPHA-DIHYDROPROGESTERONE; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; MYELIN BASIC PROTEINS; MYELIN P0 PROTEIN; MYELIN PROTEINS; NERVE FIBERS; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; PROGESTERONE; RATS; RATS, INBRED F344; SCIATIC NERVE; TAXOIDS;

EID: 62849128827     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2009.00204.x     Document Type: Article

References (47)

1. Apfel SC (2000). Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors. Cancer Invest 18 : 564 573.
2. Apfel SC, Arezzo JC, Lipson AL, Kessler JA (1992). Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31 : 76 80.
3. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P EFNS Task Force (2006). EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 : 1153 1169.
4. Azcoitia I, Leonelli E, Magnaghi V, Veiga S, Garcia-Segura LM, Melcangi RC (2003). Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol Aging 24 : 853 860.
5. Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A, Ghezzi P (2004). Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A 101 : 823 828.
6. Cavaletti G, Tredici G, Braga M, Tazzari S (1995). Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol 133 : 64 72.
7. Cavaletti G, Cavalletti E, Montaguti P, Oggioni N, De Negri O, Tredici G (1997). Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology 18 : 137 145.
8. Cavaletti G, Cavalletti E, Oggioni N, Sottani C, Minoia C, D'Incalci M, Zucchetti M, Marmiroli P, Tredici G (2000). Distribution of paclitaxel within the nervous system of the rat after repeated intraperitoneal administration. Neurotoxicology 21 : 389 393.
9. Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, Cocito D, Padua L, Ghiglione E, Manicone M, Giussani G Italian NETox Group (2006). Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst 11 : 135 141.
10. Chentanez V, Sanguanrungsirigul S, Panyasawad N (2003). Effects of ganglioside on paclitaxel (taxol) induced neuropathy in rats. J Med Assoc Thai 86 : 449 456.
11. Chomczynski P, Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162 : 156 159.
12. Cliffer KD, Siuciak JA, Carson SR, Radley HE, Park JS, Lewis DR, Zlotchenko E, Nguyen T, Garcia K, Tonra JR, Stambler N, Cedarbaum JM, Bodine SC, Lindsay RM, DiStefano PS (1998). Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat. Ann Neurol 43 : 46 55.
13. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, Broglio L, Granieri E, Lauria G (2008). The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131 : 1912 1925.
14. Gelmon K (1994). The taxoids: paclitaxel and docetaxel. Lancet 344 : 1267 1272.
15. Hagiwara H, Sunada Y (2004). Mechanism of taxane neurotoxicity. Breast Cancer 11 : 82 85.
16. Hamers FP, Pette C, Neijt JP, Gispen WH (1993). The ACTH- (4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats. Eur J Pharmacol 233 : 177 178.
17. Hansson P, Backonja M, Bouhassira D (2007). Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states. Pain 129 : 256 259.
18. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ (2003). Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol 1 : 274 278.
19. Ju G, Hökfelt T, Brodin J, Fahrenkrug J, Fischer JA, Frey P, Elde RP, Brown JC (1987). Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin- immunoreactive ganglion cells. Cell Tissue Res 247 : 417 431.
20. Jung-Testas I, Schumacher M, Robel P, Baulieu E-E (1996). Demonstration of progesterone receptors in rat Schwann cells. J Steroid Biochem Mol Biol 58 : 77 82.
21. Jung-Testas I, Do Thi A, Koenig H, Desarnaud F, Shazand K, Schumacher M, Baulieu E-E (1999). Progesterone as a neurosteroid: synthesis and action in rat glial cells. J Steroid Biochem Mol Biol 69 : 97 107.
22. Lauria G, Lombardi R, Borgna M, Penza P, Bianchi R, Savino C, Canta A, Nicolini G, Marmiroli P, Cavaletti G (2005). Intraepidermal nerve fiber density in rat footpad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 10 : 199 205.
23. Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi, V, Roglio I, Melcangi RC (2007). Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 144 : 1293 1304.
24. Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J (1999). Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias. Gynecol Oncol 72 : 100 101.
25. Melcangi RC, Garcia-Segura LM (2006). Therapeutic approaches to peripheral neuropathy based on neuroactive steroids. Expert Rev Neurother 6 : 1121 1125.
26. Melcangi RC, Magnaghi V, Galbiati M, Ghelarducci B, Sebastiani L, Martini L (2000). The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin? J Neurocytol 29 : 327 339.
27. Melcangi RC, Garcia-Segura LM, Mensah-Nyagan AG (2008). Neuroactive steroids: state of the art and new perspectives. Cell Mol Life Sci 65 : 777 797.
28. Nakamura-Craig M, Gill BK (1991). Effect of neurokinin A, substance P and calcitonin gene-related peptide in peripheral hyperalgesia of the rat paw. Neurosci Lett 124 : 49 51.
29. New PZ, Jackson CE, Rinaldi D, Burris H, Barohn RJ (1996). Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology 46 : 108 111.
30. Nguyen VH, Lawrence HJ (2004). Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias. J Clin Oncol 22 : 1767 1769.
31. Persohn E, Canta A, Schoepfer S, Traebert M, Mueller L, Gilardini A, Galbiati S, Nicolini G, Scuteri A, Lanzani F, Giussani G, Cavaletti G (2005). Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. Eur J Cancer 41 : 1460 1466.
32. Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cicuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G (2003). Paclitaxel and cisplatin induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res 9 : 5756 5767.
33. Quasthoff S, Hartung HP (2002). Chemotherapy-induced peripheral neuropathy. J Neurol 249 : 9 17.
34. Roglio I, Bianchi R, Giatti S, Cavaletti G, Caruso D, Scurati S, Crippa D, Garcia-Segura LM, Camozzi F, Lauria G, Melcangi RC (2007). Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci 64 : 1158 1168.
35. Roglio I, Bianchi R, Gotti S, Scurati S, Giatti S, Pesaresi M, Caruso D, Panzica GC, Melcangi RC (2008a). Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 155 : 673 685.
36. Roglio I, Giatti S, Pesaresi M, Bianchi R, Cavaletti G, Lauria G, Garcia-Segura LM, Melcangi RC (2008b). Neuroactive steroids and peripheral neuropathy. Brain Res Rev 57 : 460 469.
37. Rowinsky EK, Chaudhry V, Cornblath DR, Donehower RC (1993). Neurotoxicity of taxol. J Natl Cancer Inst 15 : 107 115.
38. Röyttä M, Horwitz SB, Raine CS (1984). Taxol-induced neuropathy: short-term effects of local injection. J Neurocytol 13 : 685 701.
39. Sahenk Z, Barohn R, New P, Mendell JR (1994). Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 51 : 726 729.
40. Savarese D, Boucher J, Corey B (1998). Glutamine treatment of paclitaxel induced myalgias and arthralgias. J Clin Oncol 16 : 3918 3919.
41. Schmidt Y, Unger JW, Bartke I, Reiters R (1995). Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp Neurol 132 : 16 23.
42. Seidman AD, Hudis CA, Albanell J, Tong W, Tepler I, Currie V, Moynahan ME, Theodoulou M, Gollub M, Baselga J, Norton L (1998). Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. J Clin Oncol 16 : 3353 3361.
43. Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave K-A (2003). Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Neurosci 9 : 1533 1537.
44. Smith GD, Seckl JR, Harmar AJ (1993). Distribution of neuropeptides in dorsal root ganglia of the rat; substance P, somatostatin and calcitonin gene-related peptide. Neurosci Lett 153 : 5 8.
45. Tredici G, Tredici S, Fabbrica D, Minoia C, Cavaletti G (1998). Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J Neurooncol 36 : 31 40.
46. Wang MS, Davis AA, Culver DG, Wang Q, Powers JC, Glass JD (2004). Calpain inhibition protects against taxol-induced sensory neuropathy. Brain 127 : 671 679.
47. Windebank AJ, Grisold W (2008). Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13 : 27 46.